Top Markets
Coin of the day
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Rang in Aktien #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Aktienkurs
$3.92
Zuletzt synchronisiert: 2025-08-14
Marktkapitalisierung
$2.34M
Veränderung (1 Tag)
-69.38%
Veränderung (1 Jahr)
0.00%
Land
US
Handel ReShape Lifesciences Inc. (RSLS)

Kategorie

Preis RSLS mit Marktkapitalisierung von B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Marktkapitalisierung von ReShape Lifesciences Inc.(RSLS)
Marktkapitalisierung: $2.34M
Mit Stand August 2026 hat ReShape Lifesciences Inc. eine Marktkapitalisierung von $2.34M. Das macht ReShape Lifesciences Inc. laut unseren Daten zum 36770th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von ReShape Lifesciences Inc. von 2019 bis 2026
RSLS im Vergleich zu den Top 5 der beliebtesten stocks
Preis für RSLS Vermögenswert B Marktkapitalisierung von B Ergebnisse
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
$2.833T +121,156,629.05%